GBI Expands Drug Product Services with Automated Fill-Finish Capabilities

  • GBI Biomanufacturing has expanded its Drug Product (DP) services to include automated sterile fill-finish capabilities.
  • The new service supports diverse client needs with options for automated and manual fill-finish at its Florida site.

GBI Biomanufacturing (GBI), a contract development and manufacturing organisation (CDMO), has expanded its Drug Product (DP) services by adding automated sterile fill-finish capabilities at its facility in Florida, USA. This development enhances GBI’s ability to provide end-to-end manufacturing solutions for both Drug Substance (DS) and DP at a single location.

The expanded capabilities offer clients flexibility through a dual approach. Manual aseptic vial filling caters to small, early-stage batches requiring special handling, while automated aseptic liquid filling, which employs ready-to-use components, supports higher-throughput production. This approach reduces human intervention, mitigates contamination risks, and enhances batch consistency, suitable for clinical and commercial-scale projects.

“Adding automated aseptic fill-finish capabilities to our service offerings strengthens our ability to meet the diverse requirements of our clients, from start-up biotech to established pharmaceutical companies,” said Karl Pinto, CEO of GBI. “Our facility is equipped with state-of-the-art technology and a team of experts, capable of delivering high-quality, regulatory-compliant drug products.”

The new three-format automated filler can handle vials, syringes, and cartridges. It supports various drug classes, including biologics, vaccines, bioconjugates, and complex large molecules, reinforcing GBI’s position as a versatile CDMO partner.

This addition aligns with GBI’s mission to simplify supply chains for its clients by offering a Single-Source Solution. By integrating DS and DP manufacturing under one roof, the company aims to achieve faster project timelines, improved scalability, and seamless regulatory compliance.

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

ELEARNING

Learn the essentials of successful biopharma outsourcing

New eLearning course distils 100+ expert interviews into 10 engaging modules.

tick Overview of outsourcing trends 
tick Expert insights and case studies 
tick Helpful resources and quizzes

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.